Abstract
Cyclooxygenase and 5-lipoxygenase pathways, which convert arachidonic acid into prostaglandins and leukotrienes, respectively, are the two major pro-inflammatory routes, whereas lipoxins, resolvins and neuroprotectins are potent endogenous anti-inflammatory mediators. Modulation of these pathways is key to control inflammation and to promote its resolution.
Keywords: eicosanoids, prostaglandins, leukotrienes, lipoxins, resolvins, inflammation
Letters in Drug Design & Discovery
Title: New Perspectives in the Modulation of the Eicosanoid Cascade in Inflammation
Volume: 2 Issue: 5
Author(s): J. Claria and M. Lopez-Parra
Affiliation:
Keywords: eicosanoids, prostaglandins, leukotrienes, lipoxins, resolvins, inflammation
Abstract: Cyclooxygenase and 5-lipoxygenase pathways, which convert arachidonic acid into prostaglandins and leukotrienes, respectively, are the two major pro-inflammatory routes, whereas lipoxins, resolvins and neuroprotectins are potent endogenous anti-inflammatory mediators. Modulation of these pathways is key to control inflammation and to promote its resolution.
Export Options
About this article
Cite this article as:
Claria J. and Lopez-Parra M., New Perspectives in the Modulation of the Eicosanoid Cascade in Inflammation, Letters in Drug Design & Discovery 2005; 2 (5) . https://dx.doi.org/10.2174/1570180054405730
DOI https://dx.doi.org/10.2174/1570180054405730 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serotonin Reuptake Inhibitors and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) The Regulation of miRNAs in Inflammation-Related Carcinogenesis
Current Pharmaceutical Design Editorial: Regenerative Medicine for Retinal Diseases
Current Tissue Engineering (Discontinued) ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design Bioinformatics-Based Identification of Selective Cationic Amphipatic Antibacterial Peptides: Aurein 1.2 Variants Case
Current Proteomics Clozapine Safety, 40 Years Later
Current Drug Safety Early-Life Immune Insult and Developmental Immunotoxicity (DIT)-Associated Diseases: Potential of Herbal- and Fungal-Derived Medicinals
Current Medicinal Chemistry MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Current Pharmaceutical Design Patented Biotechnological Applications of Serpin: an Update
Recent Patents on DNA & Gene Sequences Oxidative Stress, Endothelial Function and Angiogenesis Induced by Cell Therapy and Gene Therapy
Current Pharmaceutical Biotechnology Seeing Genes at Work in the Living Brain with Non-Invasive Molecular Imaging
Current Gene Therapy RNA Interference as A Gene-Specific Approach for Molecular Medicine
Current Medicinal Chemistry Antioxidants Are Not Useful in Reducing Both Pain and Inflammation in Chronic Pancreatitis
Recent Patents on Inflammation & Allergy Drug Discovery Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs
CNS & Neurological Disorders - Drug Targets Commentary (Changes of Synaptic Plasticity in Multiple Sclerosis)
CNS & Neurological Disorders - Drug Targets Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens
Current Cancer Drug Targets Editorial: Computer-Assisted Approaches as Decision Support Systems in the Overall Strategy of Combating Emerging Diseases: Some Comments Regarding Drug Design, Vaccinomics, and Genomic Surveillance of the Zika Virus
Current Computer-Aided Drug Design Pathophysiology of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Hypertension and Angiogenesis
Current Pharmaceutical Design Can Binding Kinetics Translate to a Clinically Differentiated Drug? From Theory to Practice
Letters in Drug Design & Discovery